TuHURA Biosciences, Inc./NV — Form SCHEDULE 13D/A
Filed August 28, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
James A. Bianco filed an amended Schedule 13D/A regarding TuHURA Biosciences on 2026-08-28. The document header is provided but the actual amendment contents—including any changes to share ownership, dollar amounts, or beneficial ownership percentages—are not displayed in the filing text provided. Without the substantive schedule data, the nature and materiality of the amendment cannot be determined.
Why this rating
No concrete ownership, price, or transaction data disclosed in available text. Cannot assess materiality without amendment substance relative to $111M market cap.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.